search
Back to results

Strength After Breast Cancer (SABC)

Primary Purpose

Breast Cancer

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Strength After Breast Cancer
Sponsored by
MGH Institute of Health Professions
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Breast Cancer focused on measuring Physical Therapy, Exercise Program

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: ≥18 years of age Diagnosed with Stage I-III breast cancer, having completed primary cancer treatment (e.g., surgery, chemotherapy, radiation therapy); hormonal therapies and adjuvant targeted therapies will be permitted Exclusion Criteria: Any injury or medical condition that would prohibit being able to safely perform exercise as indicated by the Physical Activity Readiness Questionnaire (i.e., atrial fibrillation, chest pain or angina, uncontrolled high blood pressure or hypertension, loss of balance due to dizziness in the past 12 months, or loss of consciousness in the past 12 months). Non-English speaking

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Strength After Breast Cancer (SABC) Intervention

    Arm Description

    Participants will undergo study procedures as outlined: Complete a baseline survey regarding exercise self-efficacy, physical activity level, quality of life, and fatigue Attend a 1-on-1 physical therapy evaluation and 4 group exercise sessions at MGH Waltham After completing the 4 exercise sessions, complete follow-up surveys including a program satisfaction survey At 1-month post-program, complete follow-up surveys and an individual, semi-structured interview with study staff to supply feedback about the program. At 3-months post-program, complete follow-up surveys

    Outcomes

    Primary Outcome Measures

    Screening Rate
    Number patients screened / Number patients identified as potentially eligible. Screening rate of at least 75% will indicate feasibility.
    Eligibility Rate
    Number patients screening eligible / Number screened. Eligibility rate of at least 75% will indicate feasibility.
    Enrollment Rate
    Number participants enrolled / Number screened positive & eligible. A rate of at least 75% will indicate feasibility.
    Program completion rate
    Number participants completing 4 sessions of the SABC intervention / Number of participants enrolled. For this study, the investigators will consider it feasible if 75% of participants complete all 4 sessions.
    Intervention session completion rate
    Number of completed sessions per participant. For this study, the investigators will consider it feasible if the mean number of sessions completed per participant is ≥ 3.
    Assessment completion rate
    Number participants completing each of the 4 study assessments / Number of participants enrolled. For this study, an assessment completion rate of 75% will indicate feasibility.

    Secondary Outcome Measures

    Participant Satisfaction
    Assessed by the post-program satisfaction survey which is a 7-item survey that is rated on a 5-point Likert scale; total score range 7-35 (higher score indicates greater satisfaction). Any item on the Satisfaction survey that generates a mean score of < 4 will trigger consideration of modification to the SABC program.
    Exercise Self-Efficacy
    Assessed with the Self-Efficacy with Exercise scale which consists of nine potential exercise barriers and asks the individual to rate their confidence on a 0 (not confident) - 10 (very confident) scale that they could exercise for twenty minutes, three times per week, given each barrier (total score range 0-90; maximum score of 90 indicates highest exercise self-efficacy).
    Physical Activity Level
    Assessed using the International Physical Activity Questionnaire Long Form to assess duration and frequency of physical activity in the last seven days in domains of: job-related, transportation, housework/house maintenance/caring for family, recreation/sport/leisure-time, and time spent sitting.
    Quality of Life: Functional Assessment of Cancer Therapy - General
    Assessed using the Functional Assessment of Cancer Therapy - General (FACT-G) (28 items), which measures health-related quality of life covering four domains of well-being (physical, social/family, emotional, functional). This measure is included in and will be assessed as part of The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F). Total score range for FACT-G is 0-108 with higher scores indicating greater quality of life.
    Cancer-Related Fatigue: Functional Assessment of Chronic Illness Treatment - Fatigue, Fatigue subscale
    Assessed using the Functional Assessment of Chronic Illness Treatment - Fatigue (FACIT-F), 13 item fatigue subscale. Total score for 13-item fatigue subscale is 0-52 with higher score indicating worse fatigue.

    Full Information

    First Posted
    September 12, 2023
    Last Updated
    September 25, 2023
    Sponsor
    MGH Institute of Health Professions
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06052488
    Brief Title
    Strength After Breast Cancer
    Acronym
    SABC
    Official Title
    Strength After Breast Cancer: Clinical Implementation of an Evidence-based Group Exercise Intervention for Breast Cancer Survivors
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 2023 (Anticipated)
    Primary Completion Date
    September 2024 (Anticipated)
    Study Completion Date
    March 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    MGH Institute of Health Professions

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The goal of this study is to explore whether a group exercise program called Strength After Breast Cancer can be delivered in an outpatient physical therapy clinic to improve physical function among women after treatment for breast cancer. The main questions this study aims to answer are: Can the Strength After Breast Cancer program and the associated outcome battery be successfully delivered in an outpatient physical therapy clinic at Massachusetts General Hospital and do participants find the program practical? What are the barriers to and facilitators of delivering the group exercise program in a clinical setting and what changes need to be made to the program to improve sustainability and to facilitate implementation at other clinical sites? Participants will complete study questionnaires before and after engaging in the group exercise program and they will participate in interviews following participation in the program.
    Detailed Description
    The goal of this single arm feasibility study of the Strength After Breast Cancer (SABC) evidence-based group exercise intervention for women after treatment for breast cancer is to determine if investigators can feasibly deliver the program out of the outpatient physical therapy clinic at Massachusetts General Hospital Waltham. - Following a one-on-one physical therapy evaluation, the four-session SABC program provides a group-based but individualized exercise plan and encourages engagement in independent home-based exercises to improve physical function. The SABC program has previously been found to be safe and led to improvements in physical function among women after treatment for breast cancer. Therefore, the focus of this study is to explore clinical implementation barriers, facilitators, and necessary program adaptations to enhance sustainability and facilitate implementation at other clinical sites. Study procedures include screening for eligibility, in-clinic visits, questionnaires, and a semi-structured interview. Participation in this research study is expected to last up to 5 months. It is expected that up to 40 people will take part in this research study. This is an unfunded study.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Breast Cancer
    Keywords
    Physical Therapy, Exercise Program

    7. Study Design

    Primary Purpose
    Health Services Research
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    40 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Strength After Breast Cancer (SABC) Intervention
    Arm Type
    Experimental
    Arm Description
    Participants will undergo study procedures as outlined: Complete a baseline survey regarding exercise self-efficacy, physical activity level, quality of life, and fatigue Attend a 1-on-1 physical therapy evaluation and 4 group exercise sessions at MGH Waltham After completing the 4 exercise sessions, complete follow-up surveys including a program satisfaction survey At 1-month post-program, complete follow-up surveys and an individual, semi-structured interview with study staff to supply feedback about the program. At 3-months post-program, complete follow-up surveys
    Intervention Type
    Behavioral
    Intervention Name(s)
    Strength After Breast Cancer
    Intervention Description
    Individual physical therapy evaluation and 4 group-based exercise sessions led by a licensed physical therapist
    Primary Outcome Measure Information:
    Title
    Screening Rate
    Description
    Number patients screened / Number patients identified as potentially eligible. Screening rate of at least 75% will indicate feasibility.
    Time Frame
    At screening
    Title
    Eligibility Rate
    Description
    Number patients screening eligible / Number screened. Eligibility rate of at least 75% will indicate feasibility.
    Time Frame
    At screening
    Title
    Enrollment Rate
    Description
    Number participants enrolled / Number screened positive & eligible. A rate of at least 75% will indicate feasibility.
    Time Frame
    At screening
    Title
    Program completion rate
    Description
    Number participants completing 4 sessions of the SABC intervention / Number of participants enrolled. For this study, the investigators will consider it feasible if 75% of participants complete all 4 sessions.
    Time Frame
    Up to 2 months
    Title
    Intervention session completion rate
    Description
    Number of completed sessions per participant. For this study, the investigators will consider it feasible if the mean number of sessions completed per participant is ≥ 3.
    Time Frame
    Up to 2 months
    Title
    Assessment completion rate
    Description
    Number participants completing each of the 4 study assessments / Number of participants enrolled. For this study, an assessment completion rate of 75% will indicate feasibility.
    Time Frame
    Up to 5 months
    Secondary Outcome Measure Information:
    Title
    Participant Satisfaction
    Description
    Assessed by the post-program satisfaction survey which is a 7-item survey that is rated on a 5-point Likert scale; total score range 7-35 (higher score indicates greater satisfaction). Any item on the Satisfaction survey that generates a mean score of < 4 will trigger consideration of modification to the SABC program.
    Time Frame
    Up to 2 months
    Title
    Exercise Self-Efficacy
    Description
    Assessed with the Self-Efficacy with Exercise scale which consists of nine potential exercise barriers and asks the individual to rate their confidence on a 0 (not confident) - 10 (very confident) scale that they could exercise for twenty minutes, three times per week, given each barrier (total score range 0-90; maximum score of 90 indicates highest exercise self-efficacy).
    Time Frame
    Up to 5 months
    Title
    Physical Activity Level
    Description
    Assessed using the International Physical Activity Questionnaire Long Form to assess duration and frequency of physical activity in the last seven days in domains of: job-related, transportation, housework/house maintenance/caring for family, recreation/sport/leisure-time, and time spent sitting.
    Time Frame
    Up to 5 months
    Title
    Quality of Life: Functional Assessment of Cancer Therapy - General
    Description
    Assessed using the Functional Assessment of Cancer Therapy - General (FACT-G) (28 items), which measures health-related quality of life covering four domains of well-being (physical, social/family, emotional, functional). This measure is included in and will be assessed as part of The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F). Total score range for FACT-G is 0-108 with higher scores indicating greater quality of life.
    Time Frame
    Up to 5 months
    Title
    Cancer-Related Fatigue: Functional Assessment of Chronic Illness Treatment - Fatigue, Fatigue subscale
    Description
    Assessed using the Functional Assessment of Chronic Illness Treatment - Fatigue (FACIT-F), 13 item fatigue subscale. Total score for 13-item fatigue subscale is 0-52 with higher score indicating worse fatigue.
    Time Frame
    Up to 5 months

    10. Eligibility

    Sex
    Female
    Gender Based
    Yes
    Gender Eligibility Description
    These eligibility criteria are aligned with the criteria outlined by the developers of the Strength After Breast Cancer program. This program was developed for women after treatment for breast cancer.
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: ≥18 years of age Diagnosed with Stage I-III breast cancer, having completed primary cancer treatment (e.g., surgery, chemotherapy, radiation therapy); hormonal therapies and adjuvant targeted therapies will be permitted Exclusion Criteria: Any injury or medical condition that would prohibit being able to safely perform exercise as indicated by the Physical Activity Readiness Questionnaire (i.e., atrial fibrillation, chest pain or angina, uncontrolled high blood pressure or hypertension, loss of balance due to dizziness in the past 12 months, or loss of consciousness in the past 12 months). Non-English speaking
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Stephen Wechsler, DPT, PhD
    Phone
    774-217-3221
    Email
    swechsler@mghihp.edu
    First Name & Middle Initial & Last Name or Official Title & Degree
    Kathleen Lyons, ScD, OTR/L
    Email
    klyons2@mghihp.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Stephen Wechsler, DPT, PhD
    Organizational Affiliation
    MGH Institute of Health Professions
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: the Partners Innovations team at http://www.partners.org/innovation. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.
    IPD Sharing Time Frame
    Data can be shared no earlier than 1 year following the date of publication
    IPD Sharing Access Criteria
    Contact the Partners Innovations team at http://www.partners.org/innovation
    IPD Sharing URL
    http://www.partners.org/innovation

    Learn more about this trial

    Strength After Breast Cancer

    We'll reach out to this number within 24 hrs